U.S. Markets open in 6 hrs 3 mins

Sierra Oncology, Inc. (SRRA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
54.75+0.02 (+0.04%)
At close: 04:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.57
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 354.97
52 Week Low 314.91
50-Day Moving Average 347.30
200-Day Moving Average 329.52

Share Statistics

Avg Vol (3 month) 3594.4k
Avg Vol (10 day) 3251.83k
Shares Outstanding 515.05M
Implied Shares Outstanding 6N/A
Float 89.65M
% Held by Insiders 18.59%
% Held by Institutions 163.10%
Shares Short (Apr 28, 2022) 41.01M
Short Ratio (Apr 28, 2022) 40.92
Short % of Float (Apr 28, 2022) 46.90%
Short % of Shares Outstanding (Apr 28, 2022) 44.14%
Shares Short (prior month Mar 30, 2022) 41.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 22, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Jan 22, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-54.52%
Return on Equity (ttm)-97.61%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-59.95M
EBITDA -94.28M
Net Income Avi to Common (ttm)-94.66M
Diluted EPS (ttm)-7.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)104.75M
Total Cash Per Share (mrq)4.43
Total Debt (mrq)853k
Total Debt/Equity (mrq)0.89
Current Ratio (mrq)8.34
Book Value Per Share (mrq)6.56

Cash Flow Statement

Operating Cash Flow (ttm)-78.96M
Levered Free Cash Flow (ttm)-42.85M